Lejie Cao Selected Research

Lejie Cao Research Topics

Disease

20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 09/2013
8	Neoplasms (Cancer) 02/2024 - 09/2013
6	Disease Progression 02/2024 - 12/2020
5	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2020
3	Carcinoma (Carcinomatosis) 10/2022 - 10/2021
3	Exanthema (Rash) 11/2021 - 01/2019
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 01/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 10/2021 - 06/2004
1	Body Weight (Weight, Body) 10/2022
1	Heart Failure 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Neutropenia 01/2022
1	Cough 10/2021
1	Dyspnea (Shortness of Breath) 10/2021
1	Chest Pain (Chest Pains) 10/2021
1	Tumor Lysis Syndrome 10/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Diarrhea 01/2019
1	Stomatitis 01/2019
1	Breast Neoplasms (Breast Cancer) 03/2015
1	Plasma Cell Granuloma 06/2004
1	Lung Diseases (Lung Disease) 06/2004

Drug/Important Bio-Agent (IBA)

4	CrizotinibIBA 02/2024 - 01/2020
4	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2020
3	Anaplastic Lymphoma KinaseIBA 02/2024 - 01/2022
3	ensartinibIBA 02/2024 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2021
3	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2022 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2015
2	PlatinumIBA 01/2023 - 01/2022
2	sugemalimabIBA 01/2023 - 01/2022
2	pembrolizumabIBA 01/2023 - 10/2021
2	Pemetrexed (MTA)FDA Link 01/2023 - 01/2021
2	LigandsIBA 01/2023 - 12/2022
2	camrelizumabIBA 12/2022 - 01/2021
2	Gefitinib (Iressa)FDA Link 11/2022 - 11/2022
2	aflutinibIBA 11/2022 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2004
2	Vorinostat FDA Link 03/2015 - 09/2013
2	ProteomeIBA 03/2015 - 09/2013
2	Histone Deacetylase InhibitorsIBA 03/2015 - 09/2013
1	toripalimabIBA 01/2024
1	atezolizumabIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	alectinibIBA 01/2022
1	EnzymesIBA 11/2021
1	Circulating Tumor DNAIBA 01/2021
1	osimertinibIBA 12/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	HMPL-013IBA 01/2020
1	SteroidsIBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	AfatinibIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2015
1	Lysine (L-Lysine)FDA Link 09/2013
1	Histones (Histone)IBA 09/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2004

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2024 - 01/2020
7	Therapeutics 11/2022 - 09/2013
2	Immunotherapy 01/2024 - 01/2021